During aging, there is an increase in neurodegenerative diseases and a decrease in cognitive performance. Postmenopausal women are more vulnerable as their estrogen levels decline, but most hormone replacement therapies do not prevent cognitive decline. One potential reason is that the timing of hormone replacement is critical and changes in the estrogen receptor expression may over-ride hormonal intervention. In rodents, estrogen receptor b (ERb) mRNA decreases in the cortex with age. One mechanism by which ERb mRNA could be regulated is by epigenetic modification of ERb promoter. Here, we show an increase in methylation of ERb promoter corresponding to decrease in ERb mRNA in the cortex of an aging female.
Introduction
The importance of estrogens, such as, 17b-estradiol in cognitive function, has been demonstrated in studies of cognition in relation to phases of the menstrual cycle, menopausal symptoms, circulating hormone levels, and aging [1, 2] . Estrogen exerts physiological effects on target tissues by binding to the nuclear receptors, estrogen receptors a and b (ERa and ERb) [3, 4] . ERa and ERb are differentially expressed throughout the rodent brain in both neurons and glial cells [5] . ERb mRNA is concentrated in the cerebral cortex and hippocampus and other brain regions that indicate nonreproductive actions of E2 [6, 7] . ERa and ERb are expressed in the hippocampus, a region of the brain involved in cognitive function [8] , but only ERb is expressed in the cortex of an adult rodent [6] . It has previously been hypothesized that diminished responsiveness to E2 in aging may be mediated by a decrease in the density of estrogen receptors, such as ERb. In the cerebral cortex, ERb mRNA expression decreases by middle age [9, 10] . It is interesting to note that, this decline in receptor expression correlates with the cognitive decline seen in middle-aged rats [11] .
This change in ERb mRNA expression with aging could be regulated by a variety of mechanisms. One potential mechanism of ERb gene regulation is through epigenetic modification of the ERb promoter. Epigenetic regulation involves postreplication and posttranslational modification of DNA and histones that lead to lasting changes in the chromatin structure and thus changes in gene transcription [12] . Methylation involves recruitment of several families of proteins including the DNA methyltransferases and the methyl-CpG-binding domain proteins [13, 14] . Recruitment of these proteins to the promoter region of a gene can result in gene silencing [15, 16] . Methyl-CpG-binding domain proteins such as methyl-CpG-binding protein 2 (MeCP2) have been shown to play a crucial role in the neural development [14] . In breast cancer cells, all have been shown to interact with the ER promoters [17] . In these studies, we investigated the role of DNA methyltransferases and MeCP2 in regulating ERb gene expression.
Methods

Real-time polymerase chain reaction
Cortical tissue was homogenized and RNA was isolated using TriZol. RNA (1 mg) was reverse transcribed (Invitrogen, Carlsbad, California, USA). For PCR, each reaction contained diethylpyrocarbonate H 2 O up to 25 ml, 12.5 ml of 2 Â SYBRGreen Brilliant Master Mix (Stratagene, Santa Clara, California, USA), 250 pmol of upstream primer, 50 pmole of downstream primer, 0.375 ml of reference dye, and 1 mg of cDNA. Each 96-well plate had a nontemplate control and each sample was run in triplicate. The change in threshold cycle (DCt) for each sample was normalized to the control gene histone 3.1. The cycling parameters and primers used for each gene have been described previously [18] .
Methylation-specific polymerase chain reaction
Genomic DNA was extracted from the cortex of young and middle-aged female rat using previously described methods [19] . In brief, tissue was homogenized in 250 ml of lysis solution [Tris-HCl (10 mM), EDTA (150 mM), 1% SDS, proteinase K (100 g/ml)] and incubated for 20 min at 551C. RNase solution (100 ml), consisting of Tris-HCl (10 mM; pH 8.0), EDTA (1 mM; Tris-EDTA), and 30 units of RNase was added, and the mixture was incubated at 371C for 1 h. DNA was purified by phenol-chloroform extraction. Sodium bisulfite modification was conducted on 500 ng of genomic DNA using the EZ Methylation Gold kit (Zymo Research, Irvine, California, USA). PCRs were done with the FailSafe PCR system protocol (Epicenter, Madison, Wisconsin, USA) as previously described [20] . The primers were designed using Meth-Primer [21] with ERb promoter sequence (gi: 83031780) used as a template.
Pyrosequencing
We examined the methylation status of specific CpG dinucleotides within the promoter region of rat ERb. Genomic DNA was extracted from the cortex of young and middle-aged female rats (n = 6-8), as described above. Pyrosequencing was performed by EpigenDx, as previously described [22] . In brief, sodium bisulfite modification was conducted on the genomic DNA. PCR was performed using HotStar Taq Polymerase (Qiagen, Germantown, Maryland, USA). Each reaction contained the following: 1X PCR buffer, MgCl 2 (3 mM), 200 mM of each deoxynucleotides triphosphate, forward primer (6 pmol), reverse primer (6 pmol), HotStar Taq Polymerase (0.75 U), bisulfite-treated DNA and water (1 ml) to adjust to proper volume. PCR conditions were as follows: 951C for 15 min; 30 Â (951C for 30 s; Ta1C for 30 s; 721C for 30 s); 721C for 5 min. Universally methylated and unmethylated DNA samples were used as controls in these experiments.
Chromatin immunoprecipitation assay
For chromatin immunoprecipitation assays, we used the Upstate Biotechnologies ChIP Assay Kit (Catalog no. 17-295, Temecula, California, USA) and methods previously described [18] . In brief, cortex was dissected and minced. Proteins were crosslinked in 1% formaldehyde and tissue was placed in the lysis buffer including protease inhibitors (Roche Applied Science, Indianapolis, Indiana, USA). Crosslinked DNA was sheared to 500 bp and sonicated cell supernatant was diluted 10-fold in ChIP dilution buffer. A sample was removed after dilution and called the 'input' sample. The remaining diluted cell supernatant was precleared with salmon sperm DNA/ protein A agarose (50% slurry). Primary MeCP2 antibody (Upstate Biotechnology, Charlottesville, Virginia, USA; 1 : 1000) was added to the remaining precleared supernatant and incubated overnight. Agarose was pelleted by centrifugation and the complex was washed with low-salt immune complex wash buffer and high-salt immune complex wash buffer, followed by LiCl complex wash buffer and Tris-EDTA buffer and eluted in elution buffer. Crosslinks were reversed and DNA was recovered. Standard PCR with 30 cycles was performed on the resulting sample as well as on the 'input' incubated samples that did not undergo any preclearing or immunoprecipitation. Resulting sample was also immunoprecipitated with a nonimmune antibody.
Results
Experiment 1: ERb mRNA and protein expression in the cortex decrease in middle-aged rats Using real-time PCR and western blot, we examined ERb mRNA and protein expression in young (3-4 months) and middle-aged (9-12 months) female rats (n = 7-10 per group). ERb mRNA was significantly decreased in the cortex in middle-aged female rats compared with young female rats (Fig. 1a ). We also investigated changes in the ERb mRNA expression in cerebellum. The ERb mRNA expression was high in the cerebellum, but did not decrease in the middle age (data not shown). Protein was collected from the cortex of young and middle-aged female rats, and found a corresponding decrease in the ERb protein expression in middle-aged compared with young female rats (data not shown).
Experiment 2: methylation of the ERb exon 1 is increased in middle-age cortex
Methylation-specific PCR was conducted to test the hypothesis that decreased ERb mRNA expression during aging corresponds with changes in the methylation status of ERb exon 1. Genomic DNA was isolated and treated with sodium bisulfite and used for methylation-specific PCR using primers designed to detect the methylation status of ERb exon 1. There was significantly increased methylation at two CpG regions of the ERb exon 1 in middle-aged rats (One-way analysis of variance; P = 0.001; Fig. 1b ).
These data suggest that ERb mRNA expression may be regulated by an increase in methylation as a result of aging.
Experiment 3: pyrosequencing of CG sites along the ERb promoter during aging
To further examine the methylation status of the ERb promoter in young and middle-aged cortex, we used pyrosequencing to analyze methylation of CG sites along ERb exon 1. Genomic DNA was collected from young and middle-aged rats to determine the percent of methylation of sites along the ERb promoter 1 from -1601 to -1062 from the mRNA start site. Two-way analysis of variance comparing age and CpG site, demonstrated a significant effect of age (P = 0.001), CpG site (P = 0.001), and a significant interaction (P = 0.002; Fig. 1c ). Differences in the percent of methylation between young and middle aged were site specific and indicate that changes in methylation are not global. of the methylation status. We investigated both DNMT 1 and DNMT 3A mRNA expression in the cortex using real-time PCR. DNMT 1 and DNMT 3A mRNA levels were significantly increased in middle-aged compared with young female rats (P < 0.001; Fig. 2a ). These data suggest that changes in DNMT mRNA expression occur at the same time that ERb mRNA expression decreases and promoter methylation increases with middle age.
Experiment 5: methyl-CpG binding protein 2 is associated with the ERb exon1 in middle-aged female rats
Methyl-binding proteins also play an important role in the regulation of gene expression by stabilizing methylation of CpG sites. Here, we investigated the direct interaction of MeCP2 with ERb exon 1 in the cortex. MeCP2 was associated the ERb promoter in middle-aged cortex. MeCP2 was not associated in young animals when ERb mRNA expression was higher (Fig. 2b) . The input sample was compared to demonstrate equal starting sample quantities and the graph represents the percent of input sample. The association of MeCP2 with ERb exon 1 in middle-aged cortex suggests that methylation and recruitment of MeCP2 could account for the changes in the ERb gene expression in middle age.
Discussion
As previously described, we observed an age-associated decrease in the ERb mRNA expression in the cortex of middle-aged female rats compared with younger rats [9] . In female rats, the timing of these age-related changes in ERb expression in the cortex is correlated with a decline in cognitive function [1] [2] [3] [4] [5] . This effect in the cortex seems to be ERb specific because there is a very low level of ERa expression in the normal adult cortex [23] . In middle-aged female rats, there was also an age-associated increase in methylation of the rat ERb promoter exon 1. This change in methylation was not global. In fact, pyrosequencing analysis revealed that changes in methylation of the ERb promoter in the cortex were specific to certain CpG regions of the promoter. A focus of future studies will be to identify the importance of these specific regions for promoter function and regulation of ERb mRNA expression.
We also found an age-associated increase in the DNMT mRNA expression. This increase was seen in both DNMT1, which is responsible for maintenance of methylation status and DNMT3A, the de-novo methyltransferase responsible for initial methylation [13, 14] . These data suggest that middle age may be the beginning of these changes in methylation. We found that MeCP2 protein expression increases with middle age in general and also becomes associated with the ERb promoter. Interestingly, the association with ERb occurred in a region of exon 1 that also showed an increase in methylation as demonstrated by pyrosequencing. These data are the first to demonstrate a correlation between ERb mRNA expression and methylation of the ERb promoter in the cortex. Although it is highly likely that multiple epigenetic modifications occur, we have begun by establishing DNA methylation as a potential mechanism by which these changes occur. ERb is thought to mediate estrogen's effects on cognition in the cortex and other brain regions. A loss of expression would render E2 inactive and any potential hormone replacement would be ineffective. These data suggest that it may be necessary to not only replace decreased hormone levels, but also understand and potentially prevent the loss of the ERb as well.
Conclusion
Here, we have shown that the age-related decrease in the ERb mRNA expression is correlated with an increase in methylation of at least one region of the ERb promoter. Epigenetic modifications in the aging brain could have significant consequences on gene expression and modify cognitive function. 
